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Abstract
OBJECTIVES: To deﬁne the outcome of treatment for deep sternal wound infections (DSWIs) using direct wound closure (DC) or
vacuum-assisted therapy (VAT) based on negative vs. positive microbiological results.
METHODS: Between 1999 and 2008, 7746 patients underwent median sternotomy for cardiac surgery at our institution. Patients were
screened for DSWI and out of the cohort 159 were identiﬁed (2%). These patients were treated, either using DC or VAT with delayed
wound closure. Outcomes were retrospectively analysed to determine the effect of negative cultures at the time of closure.
RESULTS: The indication for sternotomy was CABG 51%, isolated valve 18%, CABG/valve 18% and other related cardiovascular proce-
dures 14%. Sixty-ﬁve percent of the wound infections was diagnosed during rehabilitation period. One hundred and ﬁve (66%) patients
were treated with VAT vs. 54 (34%) patients with direct closure. Coagulase negative staphylococci were found in 48% of bacterial cul-
tures. In 75% of the patients, the microbiological results were positive at time of wound closure (69.2% VAT vs. 87.0% direct closure,
P = 0.014). Out of 159 patients, 5.0% were with positive microbiological results at the time of closure readmitted vs. 5.1% with negative
microbiological results (P = 1.0). Patients with VAT stayed signiﬁcantly longer in the hospital (mean 21 ± 16 vs. 13 ± 12, P = 0.002).
CONCLUSIONS: Negative microbiological results are not mandatory before wound closure, as the rate of readmissions for recurrence
of infection showed no difference between groups. Our results also suggest that shortening of VAT despite positive microbiological
results may be feasible.
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INTRODUCTION
Median sternotomy, either partial or total, is the most common
surgical access to the heart in cardiac surgery.
Deep sternal wound infection (DSWI) is one of the most
fearful complications in cardiac surgery after a median sternot-
omy [1, 2]. The frequency of DSWI varies among cardiac centres
ranging from 0.2 to 8% [2–8].
The management of DSWI includes several approaches. The
most common treatments for DSWI are debridement with direct
wound closure (DC) and a combined therapy, which include
vacuum-assisted therapy (VAT) with delayed wound closure
[9–12]. More invasive approaches have been also described,
which are: partial sternal resection and coverage with omentum
majus or muscle ﬂaps as well as sternal osteosynthesis among
others [2, 8]. Although these approaches are well established, the
use of VAT in DSWI is the most common practice among centres
[9–13] and has been also the standard approach at our institution
over the past years.
Wound closure after DSWI depends on several factors. One of
the important factors is negative microbiological ﬁndings as well
as the surgeon’s assessment of wound granulation [12, 14, 15].
There is still controversy if wound closure should be done only
in case of negative microbiological ﬁndings. One way to achieve
this is through VAT [12, 15–17].
Our hypothesis was that negative microbiological ﬁndings are
not mandatory before wound closure in DSWI.
MATERIALS AND METHODS
Data from 7746 patients who underwent cardiac-surgical proce-
dures at our institution between January 1999 and December
2008 were prospectively collected and retrospectively analysed.
Patients with DSWI were selected according to the classiﬁcation
of El Oakley and Wright [18]; however, no further differentiation
to the speciﬁc subtypes was performed. Patients with partial as
well as total sternotomy were included. Before surgery, no
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pre- and/or postoperative bacterial eradication was performed. A
total of 159 patients (2%) developed DSWI postoperatively.
Patients were treated either with DC, which included debride-
ment, wound irrigation, rewiring, if necessary, and wound closure
using a monoﬁlament suture; no additional chest/sternum stabil-
ization was used after wound closure; or with VAT, which included
debridement, wound irrigation and the application of VAT with a
negative suction pressure ranging between 50 and 100 mmHg.
The surgeon took the ﬁnal decision, which procedure should be
applied to each patient. No standardized criteria were used;
however, before 2002, VAT was not in use at our clinic. Therefore,
wounds were directly closed, except in cases where pectoralis
plasty was needed. VAT changes were performed every 4 to 5
days (median 5 days; inter-quartile range (IQR) 4 to 6 days). A
median of two VAT changes (IQR one to three times) were per-
formed per patient. VAT therapy was performed until the wound
showed an acceptable granulation (assessment performed by the
surgeon) or bacterial clearance was achieved; once the decision
for closure was made, the wound was closed either with a mono-
ﬁlament suture in conventional technique or in cases of extensive
sternum involvement a sternectomy with pectoralis plasty was
performed by the Department of Plastic Surgery at our institu-
tion. No further differentiation was made in regard the type of
secondary wound closure performed.
DSWI patients were grouped into two groups as follows:
• VAT group: VAT with secondary/delayed wound closure;
• DC group: primary rewiring, if necessary, and primary wound
closure.
Microbiological samples were obtained intra-operatively at
the time of the ﬁrst wound revision, as well as after each de-
bridement/vacuum change. Three tissue samples were taken
(deep and superﬁcial sternal wound, respectively, sternal bone)
before each debridement. No blood samples were assayed
unless body temperature exceeded 38.5°C. However, blood
samples are not presented in this study.
An antibiotic therapy was initiated at the time of diagnosis.
The therapy was usually started with a double or triple therapy
according to our hospital standards. The antibiotics used were:
vancomycin, rifampicin, ciproﬂoxacin or dalacin. At least two or
more were applied based on the results of primary as well as
enriched cultures and continued for 4 to 6 weeks after diagnosis
of DSWI.
The baseline characteristics of VAT patients were compared
with DC patients; common outcome parameters were analysed
to evaluate the success of each method (Table 1).
The data analysis was performed with SPSS software, version
19 (SPSS, Inc., Chicago, IL, USA). Categorical variables were pre-
sented as numbers and percents and compared between groups
using Fisher’s exact test. Continuous variables are presented as
mean ± standard deviation or median with IQR and compared
using the Mann–Whitney test. The effect of microbiological ﬁnd-
ings on readmission in both groups was analysed using the
Mantel–Haenszel chi-square test. A P-value < 0.05 was considered
statistically signiﬁcant. Several other parameters are also shown.
RESULTS
From 159 patients with DSWI (2%), 51% underwent CABG,
18% underwent isolated valve, 18% underwent CABG/valve
and 14% underwent other procedures which include thoracic
aneurysms, aortic dissections as well as congenital repair pro-
cedures (Fig. 1).
A total of 65% of the infections were detected after patients
discharge to the rehabilitation centres. One hundred and ﬁve
patients (66%) were treated with VAC vs. 54 (34%) patients who
underwent DC. According to the microbiological ﬁndings made
at the time of DSWI diagnosis, coagulase negative staphylococci
(53.5%) were the most frequently detected bacteria in both
groups together (Fig. 2). Besides that, Staphylococcus aureus was
found in 21.8% of all cases; other bacteria were present in 24.6%
of all cases. No further classiﬁcation of other bacteria was per-
formed, since they were diversiﬁed.
Wound closure with positive microbiological results was per-
formed in a total of 119 patients (75%); in 40 patients (25%),
wound closure was performed with negative microbiological
ﬁndings. Wound closure with positive microbiological ﬁndings
was performed in signiﬁcantly higher frequencies in the DC
group (87% DC, n = 47/54 vs. 69% VAT n = 72/105, P = 0.012). The
readmission rate of patients who received a wound closure,
either DC or VAT, with positive microbiological ﬁndings was
comparable between groups (5.0%, n = 6/119 vs. 5.1%, n = 2/40,
P = 1.0). No effect of positive microbiological ﬁndings on re-
admission in a stratiﬁed analysis by DC was identiﬁed (Mantel–
Haenszel P = 0.69, common odds ratio 0.71 for reduced risk
of readmission for positive microbiological ﬁndings (95%
CI 0.13–3.9)).
In addition, patients receiving a VAT had a signiﬁcant longer
hospital stay (mean 21 ± 16 vs. 13 ± 12, P = 0.002). No signiﬁcant
difference was detected between groups with regards to the
length of ICU stay (VAC mean 4 ± 5 vs. DC mean 3 ± 2, P = 0.353).
The overall 90-day mortality was 3.1% (5/159) (DC 5.5%, 3/54 vs.
VAC 1.9%, 2/105, P = 0.338). All patients died of multiorgan
failure due to severe sepsis.
Table 1: Patient characteristics in the VAT and DC groups
VAT group DC group P-value
Preoperative
Age (years) 63.6 ± 11.6 66.6 ± 10.5 0.08
Sex (male, %) 79.0 85.2 0.40
Body mass index (kg/m2) 28.5 ± 6.4 27.9 ± 4.1 0.66
COPD (%) 19.0 13.0 0.38
Diabetes mellitus (%) 31.7 31.5 1.00
LVEF (%) 53.2 ± 15 54.7 ± 14.7 0.91
EuroSCORE (logistic) 10.3 ± 12.5 9.4 ± 11.2 0.56
Creatinine (µmol/l) 107.6 ± 70.3 107.7 ± 55.2 0.92
Reoperation (%) 9.5 7.4 0.77
Intraoperative
Bilateral use of ITA (%) 21.00 22.2 0.84
ECC time (min) 89.3 ± 78.4 119 ± 85.4 0.09
Emergency operation (%) 8.6 3.7 0.34
Cross clamp time (min) 45.9 ± 47.2 61.4 ± 54.9 0.11
Postoperative
Length of ICU stay (days) 4.08 ± 5.02 3.2 ± 2.3 0.35
Length of hospital stay (days) 21.10 ± 16.4 13.3 ± 12.1 0.00
Positive culture (%) 69.2 87 0.02
COPD: chronic obstructive pulmonary disease; LVEF: left ventricular
ejection fraction; ITA: internal thoracic artery; ECC: extracorporeal
circulation; ICU: intensive care unit. A
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DISCUSSION
This study demonstrates that negative microbiological results are
not mandatory before wound closure, as these do not inﬂuence
the rate of readmissions for recurrent infection. Furthermore, the
results presented here suggest that shortening of VAT despite
positive microbiological results may be feasible.
Since the study published by Fleischmann et al. in 1993 [10],
VAC therapy established itself as a standard therapy for infected
wounds. In 1997, Morykwas et al. [13] highlighted some of the
mechanisms of wound healing caused by VAT. According to this
and several other works, VAC therapy induces wound healing
through the following mechanisms: wound contraction, neo-
vascularization, wound granulation, secretion removal and bac-
terial clearance [9–11, 13].
Wound closure should be performed in the granulation
phase while using VAT [14]. The time of wound closure has not
been well established and relies vastly on surgeon’s experience.
Several attempts have been made to try to establish a standard
protocol, although all of these are based on subjective para-
meters [9, 12, 14, 15]. This study showed that total bacterial
clearance might not be mandatory for wound closure after
DSWI.
At our institution, microbiological samples were taken on a
regular basis at the time of diagnosis of DSWI and, if a VAC
therapy was performed, after each VAT system change. The idea
behind microbiological samples is based on the appropriate se-
lection of antibiotics as well as a help to establish the appropri-
ate timing for wound closure after DSWI [12, 19]. According to
our clinic experience, wound closure after DSWI, either primary
or delayed, will be performed most of the time based on the
optical assessment performed by the surgeon and not solely
based on microbiological ﬁndings.
This study showed that although 119 (75%) patients had posi-
tive microbiological ﬁnding at the time of wound closure, the re-
infection rate based on readmissions after wound closure
showed no difference between the DC and VAT groups. Even
though this analysis did not show a statistical signiﬁcant differ-
ence, the tendency appears to be clear and correlate to other
studies already published [2, 12].
One recent study presented by Diefenbeck et al. [12] showed
a total of 24 patients with deep wound infections on upper and
lower extremities. Fourteen from 24 patients showed bacterial
growth at the time of wound closure. According to their results,
18 out of 24 patients showed no signs of reinfection. In line with
the results presented here, the authors concluded that even
Figure 1: Operations performed in the complete cohort (n = 159) as well as within groups. Values are presented in percentages. VAT: vacuum-assisted therapy; DC:
direct closure; CABG: coronary artery bypass graft; C/V: combined surgery (CABG and Valve); other: include congenital surgery and thoracic aorta surgery.
Figure 2: Bacteria found in the microbiological ﬁndings presented for the complete cohort (n = 159) as well as within groups. Values are presented in percentages.
VAT: vacuum-assisted-therapy; DC, direct closure; CoNS: coagulase negative staphylococci. Other bacteria included a diversiﬁed group of bacteria and fungi; the
amounts of cases were too small to be presented as a single parameter.
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though VAT increased granulation without necrosis, positive
microbiological ﬁndings were showed by more than 50% of the
patients at the time of wound closure without having an inﬂu-
ence on wound healing and clinical outcome. Other studies
already published have even shown a no-consistent effect of
bacterial clearance with even increase in bacterial loading and
no difference in overall healing an reduction in wound surface
area [15–17, 20]. Therefore, microbiological results are not useful
as an indicator for wound closure and a total bacterial clearance
may not be necessary. Despite these studies, the beneﬁcial
effects of VAT on wound healing have been showed in several
other studies [8, 21, 22].
Our results are in contrast to earlier studies [8, 23, 24], suggest-
ing that early application of sternal wires or direct closure favours
reinfection as well as duration of hospital stay. According to the
results shown here, there was no difference between our groups
in terms of reinfection based on readmission rate or length of ICU
stay. The use of VAT did prolong the duration of hospital stay.
Even though the 90-day mortality in our study was higher in
the DC group (3/54 vs. 2/105 VAT group), these results were not
signiﬁcant (P = 0.338). Interestingly, these results differ from
results presented in earlier studies showing a mortality rate
ranging from 14 to 26% [8, 21]. In our series, patients in both
groups died of multi-organ failure caused by severe sepsis.
Although our ﬁndings question microbiological ﬁndings as an
indicator to determine the time of wound closure, we do believe
that microbiological ﬁndings are necessary to establish the correct
antibiotic therapy. Furthermore, there was no signiﬁcant beneﬁt
using VAT in terms of reinfection rates. The baseline characteristics
as well as risk factors presented in this work are comparable to
those presented in several publications regarding DSWI and
outcome after therapy [2, 4, 5, 7, 8, 22, 25]. At our institution, VAT
is still the standard therapy for DSWI and is performed in most
DSWI cases, but our results suggest that shortening of VAT might
be feasible and even beneﬁcial for some patients.
In conclusion, this study shows that negative microbiological
results are not mandatory before wound closure, and do not in-
ﬂuence the rate of readmissions for recurrent infection.
Furthermore, shortening of VAT despite positive microbiological
results may be feasible.
LIMITATIONS
All disadvantages of a non-randomized, retrospective design
apply. It cannot be excluded that the decision for primary
closure vs. delayed closure and VAT was biased and therefore
may have impacted the results. Finally, to conﬁrm the ﬁndings
presented here, large randomized trials are necessary.
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APPENDIX. CONFERENCE DISCUSSION
Dr T. Elenbaas (Eindhoven, Netherlands): Your paper tries to answer a very im-
portant question. You only have 2% deep sternal wound infections, which I
think is very good, and even better is your outcome after treatment, the
overall mortality being only 3.1%.
Now, back to the topic of this presentation. Although I agree with the con-
clusion, I was wondering why you combined those two groups. As you men-
tioned yourself, a limitation of the study is that there is a selection bias based
on the decision of the surgeon to go for direct closure or secondary closure
after VAC therapy.
I think that these groups are not quite comparable, although the patient
characteristics, as you presented them, show more or less the same data. I
think if a patient is deep septic and the sternum is fractured in several places,
and he is haemodynamically unstable, he would probably be better off if
treatment were focused on his septicaemia and good wound drainage rather
than on direct reclosure.
First question, how is the decision made in your centre between these two
treatment modalities? The second question is about the timing of wound
closure. You stated that VAC therapy could be shorter. In your references, you
mentioned a paper from the Lund group, by Sjögren, where the C-reactive
protein level is one of the guiding factors for timing of sternal closure. My
question is, what is the value of the CRP level in your clinic in the treatment
of mediastinitis or the timing of reclosure?
And the last question concerns the readmission rate which was the same in
both groups, 5%. And the question is, what did you do when the patients
were readmitted? Was it just a week of additional antibiotic therapy or did
you have to drain the substernal space again? And how were these two add-
itional therapies divided between the two groups?
Dr Rodriguez: In regard to the ﬁrst question, why use direct closure or
vacuum-assisted therapy, that’s one of the limitations of this study. The VAT
therapy started in our clinic around 2001–02. So we knew that most of the
direct closure patients in this series were before 2001. Patients who came
with an infected wound were opened and then closed immediately after-
wards. As mentioned previously, that was between the time frame of 1999
and late 2001/2002. At this moment in our clinic we are performing
mainly VAT therapy. That’s also why the patient numbers are quite differ-
ent, 105 VAT therapy and 54 from the direct closure group. So there was
nothing behind the decision, it was just the time frame in which surgery
was performed.
We did not analyse the CRP levels with our patients. We were just analysing
the microbiology. This is the answer to your second question. And the third
question, could you repeat it?
Dr Elenbaas: What did you have to do on readmission?
Dr Rodriguez: All the patients that were readmitted came with the diagno-
sis of sternal wound infection. So all the patients that were analysed in this
paper were directly taken to the OR and were opened. Debridement was
performed and either direct closure or VAT therapy was performed.
Dr T. Gudbjartsson (Reykjavik, Iceland): I was wondering what was the
length of the follow-up? And do you have any information on chronic ﬁstulas
in the groups? And my other question is about the cultures: how were
they performed, how were they veriﬁed, was it a tissue sample or was it
just a swab?
Dr Rodriguez: It was a swab probe. This is why I said we are changing right
now to biopsies to see if that has an inﬂuence. And in regard to your ﬁrst
question, could you repeat it, sir.
Dr Gudbjartsson: Did you analyse the late or the chronic ﬁstulas, are they
included in the number of patients readmitted?
Dr Rodriguez: I cannot bring to mind the number of current ﬁstulas we
had, but the ﬁstulas were treated as deep sternal wound infections so we
included all these patients. Because this is a retrospective study, we don’t
have a very long-term follow-up. Patients from 1999 or 2002 are perhaps
already dead, so we did not make a complete follow-up.
Dr Gudbjartsson: Because it could be that you had positive cultures and
you closed the patients, and they can turn up many months or years later
with a reinfection.
Dr Rodriguez: We do know that some patients with positive cultures had a
readmission rate. However, we did not analyse further. We agree that it
would be important.
Dr P. Suwalski (Warsaw, Poland): Your courage in touching upon such a dif-
ﬁcult and sensitive issue is commendable. I just wanted to ask you, in both
groups of direct closure and VAC therapy, do you leave the ﬂow drainage
once you close the chest?
Dr Rodriguez: No.
Dr Suwalski: No? It was just the direct?
Dr Rodriguez: Yes.
Dr J. Gummert (Bad Oeynhausen, Germany): Is there any time frame where
there were more direct closures done and more VAC therapy?
Dr Rodriguez: Yes, as previously mentioned, direct closure was performed
in 54 patients, 34% of patients I believe, who were closed within the time
frame from 1999 to late 2001. Afterwards, there were only very rare cases
where direct closure was performed, because of vacuum-assisted therapy.
European Journal of Cardio-Thoracic Surgery 42 (2012) 310–311 EDITORIAL COMMENT
doi:10.1093/ejcts/ezs113 Advance Access publication 16 March 2012
Re: Negative microbiological results are not mandatory
in deep sternal wound infections before wound closure
Martin Misfeld*
Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig, Germany
* Corresponding author. Leipzig Heart Center, Struempellstrasse 39, 04289 Leipzig, Germany. Tel: +49-341-8650; fax: +49-341-8651452;
e-mail: martinmisfeld@yahoo.com (M. Misfeld).
Keywords: Vacuum-assisted therapy • Deep sternal wound infection • Microbiological ﬁndings • Wound closure
Deep sternal wound infection (DSWI) is a serious complication of
cardiac surgery with high additional morbidity and mortality. The
incidence is less than 1%, but associated with mortality rates
between 14 and 47% [1]. There are multiple predisposing factors
ranging from patient-risk factors (i.e. obesity, chronic obstructive
pulmonary disease, advanced age, male sex), perioperative
patient management (i.e. antibiotic prophylaxis, hair removal,
blood transfusion, ventilation time) and the surgical procedure
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